Search

everythinglearnresearchcommunity

for

Search:↓

Most treatments for spondyloarthritis are safe, but monitoring and careful selection based on patient risks are important.

The document concludes that managing side effects of MS therapies is crucial for treatment success and patient adherence.

New treatments for lupus show promise, but more research is needed, especially for children.

A young woman had a rare skin reaction to a medication for her joint disease, and a combination therapy improved her condition.

The new chemotherapy combination of WP 631 and Epothilone B shows enhanced effectiveness against ovarian cancer but requires more research on its safety.

Skin reactions to drugs are common and can be deadly, usually requiring stopping the drug and may be better prevented with genetic testing in the future.

Drugmakers are optimistic about targeting the Wnt pathway for new treatments despite past challenges.

Tocilizumab therapy may cause skin and hair conditions like halo naevi, vitiligo, and alopecia areata.

Apremilast helps regrow hair in hard-to-treat alopecia areata.

Effective symptom management in IBD improves quality of life and prevents complications.

Frontal Fibrosing Alopecia is a poorly understood condition that is hard to treat and causes distressing hair loss.

Dermatologists are crucial for managing skin side effects in metastatic melanoma patients using vemurafenib and ipilimumab.

Thermography matched the patient's pain levels in a shingles case and might help diagnose shingles without a rash.

The document concludes that systemic therapy is becoming more important in treating head and neck cancer, with new treatments showing promise.

Different drug doses approved in Japan and the U.S. are not mainly due to different clinical responses, and ethnic factors should be considered in setting drug doses.

Young HS patients often have other physical and mental health issues, and research on HS covers a wide range of topics including genetics, triggers, treatments, and the need for more data.

Some treatments for autoimmune hair loss work, but JAK inhibitors like tofacitinib are promising for regrowth.

Nineteenth-century British drama closely reflected the era's societal values and concerns.

Biologics for severe asthma have known side effects, but some new risks need more study.

New partnerships, clinical trials, and drug approvals marked progress in therapeutic delivery in July 2018.

Adalimumab is the most effective treatment for severe hidradenitis suppurativa, but more research is needed to improve treatment options.

Any drug can cause skin reactions, but antibiotics, NSAIDs, and psychotropic drugs are more common, with some reactions being life-threatening.

COVID-19 can cause different skin issues, including rashes and hair loss.

Taking vitamin D might improve life for MS patients and reduce skin side effects from alemtuzumab treatment.

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.

Innate lymphoid cells type 1 may contribute to alopecia areata by damaging hair follicles.

Hidradenitis Suppurativa is likely an autoinflammatory disease, and better understanding its causes could improve treatments.

The meeting highlighted the importance of genetic testing and multidisciplinary approaches in pediatric dermatology.

Understanding drug interactions, side effects, and patient-specific factors is crucial for effective dermatological care.

IL6 is linked to higher risk of heart disease in people with a certain mouth condition.